Scarica l'app Stockscreener
2.57
3.63%
0.09
Precedente Chiudi:
$2.48
Aprire:
$2.56
Volume 24 ore:
1.75M
Relative Volume:
1.47
Capitalizzazione di mercato:
$233.60M
Reddito:
$70.39M
Utile/perdita netta:
$-43.97M
Rapporto P/E:
-4.9604
EPS:
-0.5181
Flusso di cassa netto:
$-23.85M
1 W Prestazione:
+6.64%
1M Prestazione:
+0.78%
6M Prestazione:
+56.71%
1 anno Prestazione:
+9.36%
Intervallo 1D:
$2.42
$2.64
Intervallo di 1 settimana:
$2.38
$2.64
Portata 52W:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.57 | 233.60M | 70.39M | -43.97M | -23.85M | -0.5181 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Ripresa | Piper Sandler | Overweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-03-01 | Iniziato | Stifel | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-10 | Iniziato | The Benchmark Company | Buy |
| 2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Iniziato | Stephens | Overweight |
| 2017-10-13 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-31 | Iniziato | Jefferies | Buy |
| 2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
Codexis (CDXS) director Parker H. Stewart receives 66,350 stock options - Stock Titan
Director at Codexis (CDXS) receives 66,350 stock options grant - Stock Titan
CODEXIS (CDXS) director receives 66,350 stock options at $2.48 strike price - Stock Titan
Codexis (CDXS) director David V. Smith granted 66,350 stock options at $2.48 - Stock Titan
Codexis (NASDAQ: CDXS) director receives 66,350 options vesting in one year - Stock Titan
Codexis (CDXS) director receives option grant for 66,350 shares - Stock Titan
Codexis (CDXS) grants director 66,350 stock options at $2.48 - Stock Titan
Codexis (CDXS) director Raymond De Vre awarded 66,350 stock options at $2.48 - Stock Titan
Codexis Inc (CDXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Codexis Inc (CDXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Codexis Inc (CDXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Codexis Inc (CDXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Codexis Inc (CDXS) Institutional Confidence - TradingKey
Codexis Inc (CDXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Codexis Inc (CDXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Codexis Inc (CDXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CDXS: All proposals, including director elections and auditor ratification, were approved without contest - TradingView
Codexis Inc Annual Shareholders Meeting Transcript - GuruFocus
Cantor Fitzgerald reiterates Codexis stock rating on oligo platform - Investing.com
CDXS Q1 2026 Earnings: EPS Beats Estimates as Company Shows Operational ProgressEPS Revision Trend - newsline.com
CDXS Stock Price, Quote & Chart - ChartMill
CDXS Q1 2026 Earnings: EPS Beats Estimates by 28.26% Despite Revenue UncertaintiesMargin Improvement Report - newsline.com
Codexis (CDXS) Hovers Near Support as Consolidation ContinuesExtension Target - newsline.com
Codexis director Raymond de Vre sells $6,173 in shares - Investing.com UK
Codexis director Raymond de Vre sells $6,173 in shares By Investing.com - Investing.com Nigeria
Codexis (CDXS) director De Vre sells 2,605 shares to cover RSU tax liability - Stock Titan
CDXS Q1 2026 Earnings: EPS Beat Despite Revenue Uncertainty, Shares SlipOperating Income Trends - newsline.com
Why Did CDXS Stock Jump 7% Today? - Stocktwits
CDXS Q1 2026 Earnings: EPS Surprise of 28% Fails to Offset Revenue UncertaintyEarnings Revision Downgrade - newsline.com
CDXS Q1 2026 Earnings: Narrower-Than-Expected Loss Signals ProgressProduct Revenue Analysis - newsline.com
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA - Caledonian Record
Codexis Inc. (CDXS) Posts Modest Gains, Hovers Between Key Support and Resistance LevelsSpring Pattern - newsline.com
Codexis Inc. (CDXS) Climbs 4.4% as Shares Approach Key ResistanceIron Condor Alert - The Legal Advocate
CDXS Q1 2026 Earnings: Surprise EPS Beat Despite Revenue UncertaintyEarnings Per Share - thelegaladvocate.com
CDXS Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesLow Estimate Range - thelegaladvocate.com
Codexis (CDXS) Slides 1.58% as Biotech Stock Tests Key Support at $2.37Growth Factor - The Legal Advocate
Q1 2026 Codexis Inc Earnings Call Transcript - GuruFocus
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
TradingKey - TradingKey
US$6.58: That's What Analysts Think Codexis, Inc. (NASDAQ:CDXS) Is Worth After Its Latest Results - simplywall.st
Number of shareholders of Codexis, Inc. – NASDAQ:CDXS - TradingView
Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58 - Yahoo Finance
Spotlight On Promising Penny Stocks For May 2026 - simplywall.st
MSN Money - MSN
Codexis, Inc. (NASDAQ:CDXS) Q1 2026 Earnings Call Transcript - Insider Monkey
Craig-Hallum Maintains Codexis(CDXS.US) With Buy Rating, Announces Target Price $9 - Moomoo
Codexis (NASDAQ:CDXS) Issues Quarterly Earnings Results - MarketBeat
Codexis (CDXS) Q1 2026 Earnings Transcript - AOL.com
Codexis (CDXS) Reports Q1 2026 Earnings and Highlights Growth Pr - GuruFocus
Codexis reiterates $72M-$76M 2026 revenue outlook while targeting 0.5 kilogram ECO Synthesis scale by year-end - MSN
Codexis (CDXS) Reports Strong Q1 Revenue and Upcoming Data Prese - GuruFocus
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):